IV Alpha-Lipoic Acid for Treatment of Diabetic Neuropathy

The Sydney trial in 2003 showed that 2/3 of metabolically stable diabetic patients with symptomatic (stage 2) diabetic sensorimotor polyneuropathy (DSPN) had dramatic reductions in pain.  More information on the study can be found by clicking here.

If you’d like to learn more about IV treatments in our clinic, please call 916-351-9355 to schedule a free 15 minute consultation.

Dr. Michele Raithel, ND

Posted in: Uncategorized